Biopiracy prevention in biotechnology research

Introduction

Biopiracy prevention in biotechnology research refers to the legal, ethical, and regulatory measures designed to prevent the unauthorised exploitation, commercialisation, and patenting of biological resources and associated traditional knowledge without proper permission or fair benefit sharing. Biopiracy generally occurs when individuals, research institutions, or biotechnology companies obtain biological materials or traditional knowledge from indigenous communities and local populations and use them for scientific or commercial purposes without recognising the rights and contributions of the original knowledge holders.

Biotechnology research frequently depends on biological resources such as medicinal plants, microorganisms, genetic materials, agricultural varieties, and other naturally occurring organisms. These resources may contain valuable biological properties that can be developed into pharmaceutical products, agricultural technologies, industrial enzymes, and other commercial innovations.

However, the commercial exploitation of biological resources without appropriate authorisation may deprive source countries and local communities of their legitimate benefits. It may also threaten biodiversity conservation and undermine traditional knowledge systems.

For example, obtaining medicinal plant knowledge from an indigenous community and developing a commercial pharmaceutical product without appropriate benefit-sharing arrangements may raise questions of biopiracy.

Therefore, biopiracy prevention is an essential part of biotechnology governance. It ensures lawful access to biological resources, recognition of traditional knowledge, fair distribution of commercial benefits, and protection of biodiversity.

Meaning and objectives of biopiracy prevention

Biopiracy prevention refers to the establishment of legal mechanisms and institutional safeguards that prevent the unauthorised acquisition, use, transfer, and commercial exploitation of biological resources and associated traditional knowledge.

Its principal objectives include:

Preventing unauthorised access to biological resources.

Protecting indigenous and local community knowledge.

Ensuring prior informed consent where legally required.

Promoting fair and equitable benefit sharing.

Preventing inappropriate patents over traditional knowledge.

Protecting national biodiversity and genetic resources.

Establishing accountability for biotechnology companies and research institutions.

Encouraging ethical and legally compliant scientific research.

Biopiracy prevention is particularly important for developing countries such as India, which possess significant biological diversity and extensive traditional medicinal knowledge.

Major forms of biopiracy in biotechnology research

1. Exploitation of medicinal plants

Medicinal plants are valuable sources of biological compounds used in pharmaceutical research.

Biopiracy concerns may arise when companies obtain medicinal plants or associated traditional knowledge from local communities without following applicable access and benefit-sharing requirements.

For example, traditional knowledge concerning the medicinal properties of neem, turmeric, and other plants may be used in commercial research.

The legal concern is not that every commercial use of a medicinal plant constitutes biopiracy, but that unauthorised exploitation and failure to respect applicable rights may result in unfair appropriation.

2. Misappropriation of traditional knowledge

Traditional knowledge includes information developed and maintained by indigenous peoples and local communities through generations.

It may relate to medicinal plants, agricultural practices, food preservation, biological resources, and traditional healing methods.

Biotechnology companies may use such knowledge to identify useful biological compounds or develop commercial products.

Without appropriate recognition, authorisation, and benefit-sharing arrangements, this process may result in the misappropriation of community knowledge.

3. Unauthorised patenting of biological resources

Biotechnology research may result in patent applications involving biological compounds, genetic materials, or related inventions.

Biopiracy concerns arise when patent claims improperly cover existing traditional knowledge or naturally occurring materials without satisfying the applicable requirements of novelty, inventive step, and patent eligibility.

Such patents may restrict the traditional use of biological resources by communities that have historically relied upon them.

4. Exploitation of agricultural genetic resources

Traditional agricultural varieties and indigenous crop resources are important sources of genetic diversity.

Biotechnology companies may use these resources to develop improved crop varieties, disease-resistant plants, or other agricultural products.

Biopiracy prevention requires appropriate recognition of farmers' contributions, compliance with access regulations, and fair benefit-sharing arrangements.

5. Unauthorised use of microbial resources

Microorganisms such as bacteria, fungi, and algae have significant applications in pharmaceutical development, biotechnology manufacturing, agriculture, and industrial research.

Unauthorised collection, transfer, or commercial use of microbial resources may create legal concerns under biodiversity and access-and-benefit-sharing legislation.

Major legal mechanisms for preventing biopiracy

1. Prior informed consent

Prior informed consent (PIC) is an important legal mechanism requiring appropriate permission before accessing biological resources or associated traditional knowledge where applicable.

It ensures that the provider country, competent authority, or relevant knowledge holders are informed about the intended research or commercial activity.

Consent procedures should provide information about:

The nature and purpose of the proposed research.

The biological resources being accessed.

Intended commercial applications.

Possible risks and benefits.

Proposed benefit-sharing arrangements.

Conditions governing further transfer and utilisation.

PIC helps prevent unauthorised exploitation and promotes transparency in biotechnology research.

2. Mutually agreed terms

Mutually agreed terms (MAT) establish the conditions under which biological resources and associated traditional knowledge may be accessed and utilised.

These arrangements may cover financial and non-financial benefits, research collaboration, technology transfer, intellectual property rights, and sharing of commercial returns.

They provide a contractual foundation for fair and transparent biotechnology research.

3. Access and benefit sharing

Access and benefit sharing (ABS) ensures that benefits arising from the utilisation of biological resources are distributed fairly and equitably.

Benefits may include:

Monetary payments and royalties.

Joint research opportunities.

Technology transfer.

Training and scientific education.

Sharing of research findings.

Community development initiatives.

Participation in commercial benefits.

Benefit sharing is particularly important where local communities contribute biological resources or traditional knowledge.

4. Protection of traditional knowledge

Traditional knowledge documentation is an important strategy for preventing inappropriate patent claims.

India's Traditional Knowledge Digital Library (TKDL) is a major example of this approach.

It contains documented traditional medicinal knowledge and helps patent examiners identify prior art when evaluating patent applications.

5. Patent examination and opposition

Patent authorities play an important role in preventing biopiracy through proper examination of biotechnology-related patent applications.

In India, the Patents Act, 1970, contains specific provisions addressing traditional knowledge and certain biological inventions.

Section 3(p) excludes from patentability inventions that are, in effect, traditional knowledge or an aggregation or duplication of known properties of traditionally known components.

Section 10 establishes requirements concerning patent specifications.

Sections 25 and 64 provide mechanisms for opposing or revoking patents on specified legal grounds.

These provisions help prevent the grant or continuation of inappropriate patents involving traditional knowledge.

International legal framework

1. Convention on Biological Diversity, 1992

The Convention on Biological Diversity (CBD) is one of the most important international instruments governing biodiversity conservation and access to biological resources.

It establishes three principal objectives:

Conservation of biological diversity.

Sustainable use of biological resources.

Fair and equitable sharing of benefits arising from genetic resources.

Article 15 is particularly important because it recognises the sovereign rights of states over their natural resources and establishes principles concerning access to genetic resources.

Article 8(j) addresses the knowledge, innovations, and practices of indigenous and local communities relevant to biodiversity conservation.

It also promotes the equitable sharing of benefits arising from the utilisation of such knowledge.

The CBD provides the foundation for national access-and-benefit-sharing legislation.

2. Nagoya Protocol, 2010

The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits is an important international agreement adopted under the CBD.

It establishes an international framework for regulating access to genetic resources and associated traditional knowledge.

Its important provisions include:

Article 5: Fair and equitable benefit sharing.

Article 6: Access to genetic resources.

Article 7: Access to associated traditional knowledge.

Article 12: Traditional knowledge associated with genetic resources.

Article 15: Compliance with domestic access legislation.

Article 17: Monitoring and tracking the utilisation of genetic resources.

The Protocol promotes cooperation between provider countries, research institutions, biotechnology companies, and indigenous communities.

3. Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), 1994

The TRIPS Agreement establishes minimum international standards for intellectual property protection.

Article 27 addresses patentable subject matter and allows certain exclusions from patentability.

Article 27(3)(b) addresses plant and animal inventions and the protection of plant varieties.

TRIPS is relevant to biopiracy debates because it raises questions concerning the relationship between patent protection, biodiversity conservation, traditional knowledge, and national sovereignty over biological resources.

The interaction between TRIPS and the CBD remains an important issue in international biotechnology governance.

4. International Treaty on Plant Genetic Resources for Food and Agriculture, 2001

This treaty, adopted under the Food and Agriculture Organization framework, establishes a multilateral system for access to specified plant genetic resources for food and agriculture.

It recognises the contribution of farmers to the conservation and development of plant genetic resources.

Article 9 addresses Farmers' Rights, including the protection of traditional knowledge, participation in benefit sharing, and participation in decision-making at the national level.

It is particularly relevant to biotechnology research involving agricultural genetic resources.

Indian legal framework

1. Biological Diversity Act, 2002

The Biological Diversity Act, 2002, is India's principal legislation for preventing the unauthorised exploitation of biological resources and ensuring fair benefit sharing.

Its objectives include biodiversity conservation, sustainable utilisation, and equitable sharing of benefits arising from biological resources and associated knowledge.

Important provisions include:

Section 3: Regulates access to biological resources and associated knowledge by specified persons.

Section 4: Regulates the transfer of research results relating to biological resources to certain persons.

Section 6: Regulates applications for intellectual property rights based on research or information concerning biological resources obtained from India, subject to the applicable statutory framework.

Section 18: Establishes functions of the National Biodiversity Authority.

Section 21: Addresses equitable benefit sharing.

Section 36: Provides for biodiversity conservation and sustainable use.

Section 41: Addresses Biodiversity Management Committees.

The Biological Diversity (Amendment) Act, 2023, introduced significant changes to the regulatory framework. Therefore, the amended provisions and applicable rules must be considered when evaluating present-day access and benefit-sharing obligations.

2. Patents Act, 1970

The Patents Act, 1970, provides important safeguards against inappropriate patenting of biological resources and traditional knowledge.

Section 3(c) excludes the mere discovery of a scientific principle or the formulation of an abstract theory from patentability.

Section 3(j) excludes plants and animals in whole or in part, including seeds, varieties, species, and essentially biological processes for production or propagation, subject to the statutory exceptions.

Section 3(p) excludes inventions that are, in effect, traditional knowledge or merely duplicate known properties of traditionally known components.

Section 10 establishes requirements relating to the disclosure and specification of patent applications.

Section 25 provides grounds for pre-grant and post-grant opposition, including certain grounds relating to traditional knowledge and biological source disclosure.

Section 64 provides grounds for revocation of patents.

These provisions are important tools for preventing the misappropriation of biological resources through intellectual property claims.

3. Protection of Plant Varieties and Farmers' Rights Act, 2001

The Protection of Plant Varieties and Farmers' Rights Act, 2001, recognises the contributions of farmers and plant breeders to agricultural biodiversity.

It establishes a framework for protecting plant varieties while recognising farmers' rights.

Important provisions include:

Section 14: Applications for registration of plant varieties.

Section 26: Benefit-sharing claims.

Section 39: Farmers' rights.

Section 41: Community rights.

The legislation helps prevent the unfair appropriation of indigenous agricultural varieties and recognises the role of farming communities in conserving genetic resources.

4. Traditional Knowledge Digital Library

The Traditional Knowledge Digital Library is an important Indian initiative developed through cooperation between the Council of Scientific and Industrial Research (CSIR) and the Ministry of AYUSH.

It documents traditional medicinal knowledge in a structured and searchable format.

Its purpose is to help patent examiners identify existing traditional knowledge as prior art.

This initiative became particularly important in international patent disputes involving turmeric, neem, and other traditional biological resources.

Important case laws

1. Turmeric Patent Case – University of Mississippi Medical Center (1995)

United States Patent and Trademark Office · US Patent No. 5,401,504

A patent was granted in the United States concerning the use of turmeric for wound healing.

India challenged the patent on the ground that the medicinal use of turmeric was already part of traditional Indian knowledge.

CSIR submitted evidence from traditional knowledge sources and published literature demonstrating that the claimed use was not new.

The United States Patent and Trademark Office subsequently revoked the patent following re-examination.

Legal significance: The case demonstrated that traditional knowledge can constitute prior art and that patent systems must prevent the appropriation of existing community knowledge.

Relevance: It encouraged India to strengthen traditional knowledge documentation through initiatives such as the Traditional Knowledge Digital Library.

2. Neem Patent Case – EPO Opposition (2000)

European Patent Office · Patent EP 0436257

A patent relating to the fungicidal properties of neem oil was granted to W.R. Grace and the United States Department of Agriculture.

The patent was challenged by representatives of Indian agricultural and environmental interests.

The opponents argued that the fungicidal properties and traditional applications of neem were already known in India.

The European Patent Office ultimately revoked the patent in 2000 following opposition proceedings.

Legal significance: The decision demonstrated that traditional agricultural knowledge may defeat patent claims where the claimed invention lacks the required novelty or inventive step.

Relevance: It strengthened the importance of documenting indigenous agricultural knowledge and protecting biological resources against inappropriate commercial appropriation.

3. Divya Pharmacy v. Union of India (2018)

Uttarakhand High Court · Writ Petition (M/S) No. 3437 of 2016

The dispute concerned the applicability of benefit-sharing requirements under India's biodiversity legislation to an Indian company using biological resources.

Divya Pharmacy challenged the regulatory authority's power to impose benefit-sharing obligations.

The Uttarakhand High Court upheld the relevant benefit-sharing framework and recognised the importance of equitable sharing of benefits arising from biological resources.

Legal significance: The judgment supported the application of biodiversity legislation to commercial utilisation of biological resources and reinforced the importance of benefit sharing.

Relevance: It is particularly important for biotechnology companies, pharmaceutical manufacturers, and research institutions using biological resources for commercial development.

4. Monsanto Technology LLC v. Nuziveedu Seeds Ltd. (2019)

Supreme Court of India · (2019) 3 SCC 381

The dispute concerned patent rights relating to genetically modified cotton technology and the licensing arrangements between Monsanto and Indian seed companies.

The Supreme Court set aside the Delhi High Court's decision on the patent-related issues and remanded the matter for fresh consideration.

The judgment examined questions concerning patentability, biotechnology inventions, and the relationship between patent law and plant variety protection.

Legal significance: The case demonstrates the complexity of intellectual property protection involving genetically modified agricultural technologies.

Relevance: It highlights the need to balance biotechnology innovation, patent rights, agricultural interests, and the protection of biological resources. It was not a direct biopiracy ruling.

Challenges in preventing biopiracy in biotechnology research

Despite the existence of international agreements and national legislation, biopiracy prevention faces several challenges.

First, traditional knowledge is often undocumented or maintained through oral practices within local communities. This makes it difficult to establish prior art and prove the historical origin of particular knowledge.

Second, biotechnology companies may use genetic information obtained from different countries, creating difficulties in determining the origin of biological resources and associated benefit-sharing obligations.

Third, developments in synthetic biology and digital sequence information create new regulatory questions concerning the use of genetic data without physically collecting biological materials.

Other significant challenges include:

Inadequate awareness of access-and-benefit-sharing legislation.

Difficulty identifying the original knowledge holders.

Cross-border commercial exploitation of biological resources.

Patent applications involving traditionally known biological properties.

Weak monitoring of biological resource utilisation.

Unequal bargaining power between corporations and local communities.

Difficulties in enforcing international benefit-sharing agreements.

Strengthening traditional knowledge databases, improving patent examination, and increasing community participation are essential for addressing these challenges.

Conclusion

Biopiracy prevention in biotechnology research is essential for protecting biological resources, traditional knowledge, indigenous communities, and national biodiversity interests. It ensures that scientific and commercial utilisation of biological resources takes place through lawful access, appropriate authorisation, and fair benefit-sharing arrangements.

International instruments such as the Convention on Biological Diversity, Nagoya Protocol, TRIPS Agreement, and International Treaty on Plant Genetic Resources for Food and Agriculture establish important principles for regulating access to biological resources and protecting traditional knowledge.

In India, the Biological Diversity Act, 2002, Patents Act, 1970, and Protection of Plant Varieties and Farmers' Rights Act, 2001, provide important legal safeguards. Initiatives such as the Traditional Knowledge Digital Library further strengthen India's ability to prevent inappropriate patent claims.

Judicial and patent-related decisions such as the turmeric patent case, neem patent case, Divya Pharmacy v. Union of India, and Monsanto Technology LLC v. Nuziveedu Seeds Ltd. demonstrate the importance of protecting traditional knowledge, ensuring equitable benefit sharing, and balancing intellectual property rights with biodiversity conservation.

Ultimately, effective biopiracy prevention requires cooperation between governments, patent authorities, biotechnology companies, research institutions, and indigenous communities. Such cooperation ensures that biotechnology innovation contributes to scientific progress while respecting the rights and contributions of those who conserve and develop biological resources.